138 related articles for article (PubMed ID: 29679278)
1. Overexpression of modified human TRβ1 suppresses the growth of hepatocarcinoma SK-hep1 cells in vitro and in xenograft models.
Peng X; Zhou Y; Sun Y; Song W; Meng X; Zhao C; Zhao R
Mol Cell Biochem; 2018 Dec; 449(1-2):207-218. PubMed ID: 29679278
[TBL] [Abstract][Full Text] [Related]
2. Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells.
Peng X; Zhang Y; Sun Y; Wang L; Song W; Li Q; Zhao R
Oncol Lett; 2018 Jul; 16(1):785-792. PubMed ID: 29963146
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
Martínez-Iglesias O; Garcia-Silva S; Tenbaum SP; Regadera J; Larcher F; Paramio JM; Vennström B; Aranda A
Cancer Res; 2009 Jan; 69(2):501-9. PubMed ID: 19147563
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
[TBL] [Abstract][Full Text] [Related]
5. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
8. Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity.
Park JW; Zhao L; Webb P; Cheng SY
Oncotarget; 2014 Oct; 5(20):10002-16. PubMed ID: 25275301
[TBL] [Abstract][Full Text] [Related]
9. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
10. microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.
Ruiz-Llorente L; Ardila-González S; Fanjul LF; Martínez-Iglesias O; Aranda A
Oncotarget; 2014 May; 5(10):2918-33. PubMed ID: 24796297
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
12. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
15. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625
[TBL] [Abstract][Full Text] [Related]
16. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
17. Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone.
Dupré SM; Guissouma H; Flamant F; Seugnet I; Scanlan TS; Baxter JD; Samarut J; Demeneix BA; Becker N
Endocrinology; 2004 May; 145(5):2337-45. PubMed ID: 14726446
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
19. Regulation of fibronectin by thyroid hormone receptors.
Lin KH; Chen CY; Chen SL; Yen CC; Huang YH; Shih CH; Shen JJ; Yang RC; Wang CS
J Mol Endocrinol; 2004 Oct; 33(2):445-58. PubMed ID: 15525600
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
